50
Participants
Start Date
July 11, 2024
Primary Completion Date
August 30, 2029
Study Completion Date
October 30, 2029
Non-interventional
This is a rollover study
RECRUITING
The Alfred Hospital, Melbourne
NOT_YET_RECRUITING
Fiona Stanley Hospital, Murdoch
NOT_YET_RECRUITING
University of Miami Miller School of Medicine, Miami
RECRUITING
Chang Gung Medical Foundation Linkou, Taoyuan District
RECRUITING
Taichung Veterans General Hospital, Taichung
RECRUITING
Chia-Yi Christian Hospital, Chiayi City
RECRUITING
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
RECRUITING
E-Da Hospital, Kaohsiung City
RECRUITING
Research and Education Inc., San Diego
RECRUITING
Changhua Christian Hospital, Changhua
RECRUITING
Infectious Disease Care, Hillsborough
RECRUITING
Prince of Wales Hospital, Shatin
RECRUITING
Queen Mary Hospital, Hong Kong
RECRUITING
Arensia Exploratory Medicine Moldova, Chisinau
NOT_YET_RECRUITING
Asan Medial Center, Seoul
NOT_YET_RECRUITING
University Hospital of Wales, Cardiff, Cardiff
NOT_YET_RECRUITING
Royal London Hospital, London
NOT_YET_RECRUITING
King's College Hospital, London
Lead Sponsor
Arbutus Biopharma Corporation
INDUSTRY